Iva Mucalo

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Topics

Oxide Nanoparticles

Early Breast Cancer

Ejection Fraction

Top Venues

Acta pharmaceutica (Zagreb, Croatia)

Pharmacogenomics

Healthcare (Basel, Switzerland)

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Dugonjić Okroša, Tajana Silovski, Natalija Dedić Plavetić, Hrvoje Silovski, Ana Kovačić, Iva Mucalo
Beliefs about medicines' association with endocrine therapy adherence in early breast cancer survivors in Croatia. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Andrea Brajković, Lucija Ana Bićanić, Helena Orehovački, Ingrid Prkačin, Djenane Ramalho De Oliveira, Iva Mucalo
Prescribers' approval rate of pharmacist-initiated interventions to optimise patients' clinical status of hypertension in the ambulatory care setting. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics (2023)
Andrea Brajković, Lucija Ana Bićanić, Helena Orehovački, Ingrid Prkačin, Djenane Ramalho De Oliveira, Iva Mucalo
Prescribers' approval rate of pharmacist-initiated interventions to optimise patients' clinical status of hypertension in the ambulatory care setting. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Ana Dugonjić Okroša, Tajana Silovski, Natalija Dedić Plavetić, Hrvoje Silovski, Ana Kovačić, Iva Mucalo
Beliefs about medicines' association with endocrine therapy adherence in early breast cancer survivors in Croatia. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Ana Dugonjić Okroša, Tajana Silovski, Natalija Dedić Plavetić, Hrvoje Silovski, Ana Kovačić, Iva Mucalo
Beliefs about medicines' association with endocrine therapy adherence in early breast cancer survivors in Croatia. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Andrea Brajković, Lucija Ana Bićanić, Helena Orehovački, Ingrid Prkačin, Djenane Ramalho De Oliveira, Iva Mucalo
Prescribers' approval rate of pharmacist-initiated interventions to optimise patients' clinical status of hypertension in the ambulatory care setting. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Andrea Brajković, Lucija Ana Bićanić, Marija Strgačić, Helena Orehovački, Djenane Ramalho de Oliveira, Iva Mucalo
The Impact of Pharmacist-Led Medication Management Services on the Quality of Life and Adverse Drug Reaction Occurrence. Pharmacy (Basel, Switzerland) 10 (5) (2022)
Iva Mucalo, Andrea Brajković, Marija Strgačić, Djenane Ramalho de Oliveira, Elizabeta Ribarić, Ana Bobinac
Budget Impact Analysis of Pharmacist-Led Medication Management in Cardiovascular and Type 2 Diabetic Patients. Healthcare (Basel, Switzerland) 10 (4) (2022)
Andrea Brajković, Lorena Bosnar, Mariana Martins Gonzaga do Nascimento, Ingrid Prkačin, Antonija Balenović, Djenane Ramalho de Oliveira, Iva Mucalo
Healthcare Utilisation and Clinical Outcomes in Older Cardiovascular Patients Receiving Comprehensive Medication Management Services: A Nonrandomised Clinical Study. International journal of environmental research and public health 19 (5) (2022)
Katarina Fehir Šola, Iva Mucalo, Andrea Brajković, Ivona Jukić, Donatella Verbanac, Sanda Vladimir Knežević
Drug therapy problems identified among older adults placed in a nursing home: the Croatian experience. The Journal of international medical research 48 (6) (2021)
Iva Mucalo, Maja Ortner Hadžiabdić, Andrea Brajković, Sonja Lukić, Patricia Marić, Ivana Marinović, Vesna Bačić-Vrca
Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. European journal of clinical pharmacology 73 (8) (2017)